Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Feasibility and Safety of Single Dose Ketamine for Acutely Suicidal Patients in the Emergency Department

NCT06085937 is registered in ClinicalTrials.gov with Lindsay Maguire, MD as lead sponsor.

NCT NCT06085937
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT06085937 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Feasibility and Safety of Single Dose Ketamine for Acutely Suicidal Patients in the Emergency Department
Lead sponsor
Lindsay Maguire, MD
Phase
Phase 1
Overall status
Recruiting
Start date
May 1, 2024
Completion date
April 30, 2027
Enrollment
50 (estimated)
Sites
2

Conditions

As the registry lists them; a condition with its own page is linked.

depression, suicidal ideation, suicide